Skip to content

Clinical trials

Diabetes Mellitus, Type 2 trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus, Type 2 Country / region: China Clear all

844 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20024
20035
20045
20057
20067
200711
200822
200916
201029
201126
201226
201332
201431
201533
201628
201745
201829
201947
202048
202151
202260
202358
202476
202575
202669

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed468
Unknown status181
Recruiting102
Not yet recruiting43
Active, not recruiting21
Terminated18
Enrolling by invitation5
Withdrawn5
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S66
Jiangsu HengRui Medicine Co., Ltd.36
Eli Lilly and Company31
AstraZeneca29
Sanofi24
Shanghai Jiao Tong University School of Medicine19
Sun Yat-sen University19
Boehringer Ingelheim18
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School17
Fujian Shengdi Pharmaceutical Co., Ltd.16

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus, Type 2844
Diabetes Mellitus107
Obesity60
Overweight34
Insulin Resistance23
Diabetes Mellitus, Type 118
Cognitive Dysfunction17
Diabetic Nephropathies17
Cardiovascular Diseases15
Renal Insufficiency, Chronic14

Trials

Showing 1 to 25 of 844. Each trial links to its page on Pharma Observatory.

744 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.